The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Open accessAbstract
Significant advances have been made uncovering the factors that render neurons vulnerable in Parkinson's disease (PD). However, the critical pathogenic events leading to cell loss remain poorly understood, complicating the development of disease-modifying interventions. Given that the cardinal motor symptoms and pathology of PD involve the loss of dopamine (DA) neurons of the substantia nigra pars compacta (SNc), a majority of the work in the PD field has focused on this specific neuronal population. PD however, is not a disease of DA neurons exclusively: pathology, most notably in the form of Lewy bodies and neurites, has been reported in multiple regions of the central and peripheral nervous system, including for example the locus coeruleus, the dorsal raphe nucleus and the dorsal motor nucleus of the vagus. Cell and/or terminal loss of these additional nuclei is likely to contribute to some of the other symptoms of PD and, most notably to the non-motor features. However, exactly which regions show actual, well-documented, cell loss is presently unclear. In this review we will first examine the strength of the evidence describing the regions of cell loss in idiopathic PD, as well as the order in which this loss occurs. Secondly, we will discuss the neurochemical, morphological and physiological characteristics that render SNc DA neurons vulnerable, and will examine the evidence for these characteristics being shared across PD-affected neuronal populations. The insights raised by focusing on the underpinnings of the selective vulnerability of neurons in PD might be helpful to facilitate the development of new disease-modifying strategies and improve animal models of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“Braak staging is a method of classifying the progression of PD pathology and symptoms based on the presence of Lewy pathology (where 1 represents initial pathology in the brain stem, and 6, severe pathology including the neocortex) (21).”
MethodMDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., & Seitelberger, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,651
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
The substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1437 · Cited by 1,756
Parkinson, J. (2002) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.14.2.223 · Cited by 1,628
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301
Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
Kordower, J. H., Olanow, C. W., Dodiya, H. B., Chu, Y., Beach, T. G., Adler, C. H., Halliday, G. M., & Bartus, R. T. (2013) · Brain · doi:10.1093/brain/awt192 · Cited by 1,286
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Clinical progression in Parkinson disease and the neurobiology of axons
Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012 · cited 1×
“At clinical presentation, it has been estimated that 40–60% of SNc DA neurons have already degenerated (2, 3).”
BackgroundZarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?
Reeve, A., Simcox, E., & Turnbull, D. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.01.004 · Cited by 947
Jones, B. E., & Yang, T. (1985) · Journal of Comparative Neurology · doi:10.1002/cne.902420105 · Cited by 896
Athauda, D., Maclagan, K., Skene, S. S., Bajwa-Joseph, M., Letchford, D., Chowdhury, K., Hibbert, S., Budnik, N., Zampedri, L., Dickson, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31585-4 · Cited by 889
Matsuda, W., Furuta, T., Nakamura, K. C., Hioki, H., Fujiyama, F., Arai, R., & Kaneko, T. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4029-08.2009 · Cited by 865
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Guzman, J. N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schumacker, P. T., & Surmeier, D. J. (2010) · Nature · doi:10.1038/nature09536 · Cited by 843
Mitochondrial dysfunction in Parkinson's disease
Bose, A., & Beal, M. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13731 · Cited by 841
Arendt, T., Bigl, V., Arendt, A., & Tennstedt, A. (1983) · Acta Neuropathologica · doi:10.1007/bf00697388 · Cited by 817
Hell, J. W., Westenbroek, R. E., Warner, C., Ahlijanian, M. K., Prystay, W., Gilbert, M. M., Snutch, T. P., & Catterall, W. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.4.949 · Cited by 759
Braak, H., Del Tredici, K., Bratzke, H., Hamm-Clement, J., Sandmann-Keil, D., & Rüb, U. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1301-4 · Cited by 708
the Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698
The role of protein clearance mechanisms in organismal ageing and age-related diseases
Vilchez, D., Saez, I., & Dillin, A. (2014) · Nature Communications · doi:10.1038/ncomms6659 · Cited by 689
Non-motor symptoms in Parkinson's disease
Pfeiffer, R. F. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.004 · Cited by 644
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
Sofic, E., Lange, K. W., Jellinger, K., & Riederer, P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90355-b · Cited by 590
Li, Y., Perry, T., Kindy, M. S., Harvey, B. K., Tweedie, D., Holloway, H. W., Powers, K., Shen, H., Egan, J. M., Sambamurti, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806720106 · Cited by 589
Jiang, T., Sun, Q., & Chen, S. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.005 · Cited by 586
Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation
Matheoud, D., Sugiura, A., Bellemare-Pelletier, A., Laplante, A., Rondeau, C., Chemali, M., Fazel, A., Bergeron, J. J., Trudeau, L.-E., Burelle, Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.039 · Cited by 582
Self-citationPerry, E. K., Curtis, M., Dick, D. J., Candy, J. M., Atack, J. R., Bloxham, C. A., Blessed, G., Fairbairn, A., Tomlinson, B. E., & Perry, R. H. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.413 · Cited by 571
Hypocretin (orexin) cell loss in Parkinson's disease
Thannickal, T. C., Lai, Y.-Y., & Siegel, J. M. (2007) · Brain · doi:10.1093/brain/awm097 · Cited by 566
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
Gegg, M. E., Burke, D., Heales, S. J. R., Cooper, J. M., Hardy, J., Wood, N. W., & Schapira, A. H. V. (2012) · Annals of Neurology · doi:10.1002/ana.23614 · Cited by 564
The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology
MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., & Abeliovich, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.008 · Cited by 564
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Hirsch, E. C., Graybiel, A. M., Duyckaerts, C., & Javoy-Agid, F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5976 · Cited by 554
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 534
Mosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Krantz, D. E., Kobayashi, K., Edwards, R. H., & Sulzer, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.033 · Cited by 534
Pacelli, C., Giguère, N., Bourque, M.-J., Lévesque, M., Slack, R. S., & Trudeau, L.-É. (2015) · Current Biology · doi:10.1016/j.cub.2015.07.050 · Cited by 530
Self-citationDisease‐specific patterns of locus coeruleus cell loss
German, D. C., Manaye, K. F., White, C. L., Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N., & Mann, D. M. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320510 · Cited by 512
MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping
Bilgic, B., Pfefferbaum, A., Rohlfing, T., Sullivan, E. V., & Adalsteinsson, E. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.077 · Cited by 499
Protective and toxic roles of dopamine in Parkinson's disease
Segura‐Aguilar, J., Paris, I., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 498
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495
Chan‐Palay, V., & Asan, E. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902870308 · Cited by 495
THE BRAIN-STEM LESIONS IN PARKINSONISM
Greenfield, J. G., & Bosanquet, F. D. (1953) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.16.4.213 · Cited by 494
Axon degeneration in Parkinson's disease
Burke, R. E., & O'Malley, K. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.011 · Cited by 493
Shults, C. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509567103 · Cited by 476
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
Hauser, D. N., & Hastings, T. G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 474
Hypocretin (orexin) loss in Parkinson's disease
Fronczek, R., Overeem, S., Lee, S. Y. Y., Hegeman, I. M., van Pelt, J., van Duinen, S. G., Lammers, G. J., & Swaab, D. F. (2007) · Brain · doi:10.1093/brain/awm090 · Cited by 463
Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseases
Candy, J. M., Perry, R. H., Perry, E. K., Irving, D., Blessed, G., Fairbairn, A. F., & Tomlinson, B. E. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90045-x · Cited by 459
Mitochondrial Dysfunction in Parkinson’s Disease
Moon, H. E., & Paek, S. H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.2.103 · Cited by 455
Cholinergic interneuron characteristics and nicotinic properties in the striatum
Zhou, F., Wilson, C. J., & Dani, J. A. (2002) · Journal of Neurobiology · doi:10.1002/neu.10150 · Cited by 444
Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease
Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 443
Living on the edge with too many mouths to feed: Why dopamine neurons die
Bolam, J. P., & Pissadaki, E. K. (2012) · Movement Disorders · doi:10.1002/mds.25135 · Cited by 436
Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease
Karachi, C., Grabli, D., Bernard, F. A., Tandé, D., Wattiez, N., Belaid, H., Bardinet, E., Prigent, A., Nothacker, H.-P., Hunot, S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42642 · Cited by 434
Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
Halliday, G. M., Li, Y. W., Blumbergs, P. C., Joh, T. H., Cotton, R. G. H., Howe, P. R. C., Blessing, W. W., & Geffen, L. B. (1990) · Annals of Neurology · doi:10.1002/ana.410270405 · Cited by 408
Pakkenberg, B., Moller, A., Gundersen, H. J., Mouritzen Dam, A., & Pakkenberg, H. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.1.30 · Cited by 407
Neuropathology of Autonomic Nervous System in Parkinson's Disease
Wakabayashi, K., & Takahashi, H. (1997) · European Neurology · doi:10.1159/000113469 · Cited by 407
Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization
German, D. C., Manaye, K., Smith, W. K., Woodward, D. J., & Saper, C. B. (1989) · Annals of Neurology · doi:10.1002/ana.410260403 · Cited by 396
Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration
Caudle, W. M., Richardson, J. R., Wang, M. Z., Taylor, T. N., Guillot, T. S., McCormack, A. L., Colebrooke, R. E., Di Monte, D. A., Emson, P. C., & Miller, G. W. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0319-07.2007 · Cited by 388
The pedunculopontine nucleus in Parkinson's disease
Zweig, R. M., Jankel, W. R., Hedreen, J. C., Mayeux, R., & Price, D. L. (1989) · Annals of Neurology · doi:10.1002/ana.410260106 · Cited by 386
Jellinger, K. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.4.540 · Cited by 373
Braak, H., & Del Tredici, K. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-179001 · Cited by 372
A comparison of clinical and pathological features of young‐ and old‐onset Parkinson's disease
Gibb, W. R. G., & Lees, A. J. (1988) · Neurology · doi:10.1212/wnl.38.9.1402 · Cited by 369
Singaram, C., Gaumnitz, E. A., Torbey, C., Ashraf, W., Quigley, E. M. M., Sengupta, A., & Pfeiffer, R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92707-7 · Cited by 368
Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease
Halliday, G. M., Blumbergs, P. C., Cotton, R. G. H., Blessing, W. W., & Geffen, L. B. (1990) · Brain Research · doi:10.1016/0006-8993(90)90733-r · Cited by 366
Greffard, S., Verny, M., Bonnet, A.-M., Beinis, J.-Y., Gallinari, C., Meaume, S., Piette, F., Hauw, J.-J., & Duyckaerts, C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.584 · Cited by 354
The relevance of iron in the pathogenesis of Parkinson’s disease
Sian‐Hülsmann, J., Mandel, S., Youdim, M. B. H., & Riederer, P. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07132.x · Cited by 352
Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
Pearce, R. K. B., Owen, A., Daniel, S., Jenner, P., & Marsden, C. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291884 · Cited by 350
FEDOROW, H., TRIBL, F., HALLIDAY, G., GERLACH, M., RIEDERER, P., & DOUBLE, K. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.001 · Cited by 350
Pissadaki, E. K., & Bolam, J. P. (2013) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2013.00013 · Cited by 348
Does levodopa slow or hasten the rate of progression of Parkinson’s disease?
Fahn, S., & and the Parkinson Study Group (2005) · Journal of Neurology · doi:10.1007/s00415-005-4008-5 · Cited by 347
Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature
Schneider, S. A., & Alcalay, R. N. (2017) · Movement Disorders · doi:10.1002/mds.27193 · Cited by 342
Lysosomal impairment in Parkinson's disease
Dehay, B., Martinez‐Vicente, M., Caldwell, G. A., Caldwell, K. A., Yue, Z., Cookson, M. R., Klein, C., Vila, M., & Bezard, E. (2013) · Movement Disorders · doi:10.1002/mds.25462 · Cited by 340
Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra
Rinne, J. O., Mlic, J. R., Paljärvi, L., & Rinne, U. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260107 · Cited by 331
Huisman, E., Uylings, H. B. M., & Hoogland, P. V. (2004) · Movement Disorders · doi:10.1002/mds.10713 · Cited by 313
K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons
Liss, B., Haeckel, O., Wildmann, J., Miki, T., Seino, S., & Roeper, J. (2005) · Nature Neuroscience · doi:10.1038/nn1570 · Cited by 299
The anterior olfactory nucleus in Parkinson's disease
Pearce, R. K. B., Hawkes, C. H., & Daniel, S. E. (1995) · Movement Disorders · doi:10.1002/mds.870100309 · Cited by 290
Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
Yue, M., Hinkle, K. M., Davies, P., Trushina, E., Fiesel, F. C., Christenson, T. A., Schroeder, A. S., Zhang, L., Bowles, E., Behrouz, B., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.031 · Cited by 281
Dementia in idiopathic Parkinson's disease: A neuropathological study of 32 cases
Gaspar, P., & Gray, F. (1984) · Acta Neuropathologica · doi:10.1007/bf00695605 · Cited by 275
Chan‐Palay, V. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902730409 · Cited by 273
Retrograde Axonal Degeneration in Parkinson Disease
Tagliaferro, P., & Burke, R. E. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-150769 · Cited by 272 · cited 1×
“This could lead to preferential dysregulation of axon terminals, triggering a dying back cascade culminating later in cell death (3, 183, 184).”
BackgroundJankovski, A., & Sotelo, C. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960729)371:3<345::aid-cne1>3.0.co;2-2 · Cited by 270
Parkinson's disease: Neuron loss in the nucleus basalis without concomitant Alzheimer's disease
Nakano, I., & Hirano, A. (1984) · Annals of Neurology · doi:10.1002/ana.410150503 · Cited by 259
Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders
Cai, Y., Arikkath, J., Yang, L., Guo, M.-L., Periyasamy, P., & Buch, S. (2016) · Autophagy · doi:10.1080/15548627.2015.1121360 · Cited by 258
Henderson, J. M. (2000) · Brain · doi:10.1093/brain/123.7.1410 · Cited by 244
Truban, D., Hou, X., Caulfield, T. R., Fiesel, F. C., & Springer, W. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160989 · Cited by 237
Del Tredici, K., & Braak, H. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301817 · Cited by 236
The relationship between glucocerebrosidase mutations and Parkinson disease
Migdalska‐Richards, A., & Schapira, A. H. V. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13385 · Cited by 231
K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration
Schiemann, J., Schlaudraff, F., Klose, V., Bingmer, M., Seino, S., Magill, P. J., Zaghloul, K. A., Schneider, G., Liss, B., & Roeper, J. (2012) · Nature Neuroscience · doi:10.1038/nn.3185 · Cited by 219
Nigral pathology and parkinsonian signs in elders without Parkinson disease
Buchman, A. S., Shulman, J. M., Nag, S., Leurgans, S. E., Arnold, S. E., Morris, M. C., Schneider, J. A., & Bennett, D. A. (2012) · Annals of Neurology · doi:10.1002/ana.22588 · Cited by 213
Hayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S., & Takahashi, H. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<884::aid-mds1019>3.0.co;2-8 · Cited by 212
Lewy Body Pathology in Normal Elderly Subjects
Markesbery, W. R., Jicha, G. A., Liu, H., & Schmitt, F. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ac10a7 · Cited by 210
Lohr, K. M., Bernstein, A. I., Stout, K. A., Dunn, A. R., Lazo, C. R., Alter, S. P., Wang, M., Li, Y., Fan, X., Hess, E. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402134111 · Cited by 209
Calcium and Parkinson's disease
Surmeier, D. J., Schumacker, P. T., Guzman, J. D., Ilijic, E., Yang, B., & Zampese, E. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.168 · Cited by 202
Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons
Guillot, T. S., & Miller, G. W. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8059-y · Cited by 201
The nucleus basalis of Meynert in neurological disease: A quantitative morphological study
Rogers, J. D., Brogan, D., & Mirra, S. S. (1985) · Annals of Neurology · doi:10.1002/ana.410170210 · Cited by 200
Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss
Annerino, D. M., Arshad, S., Taylor, G. M., Adler, C. H., Beach, T. G., & Greene, J. G. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1040-2 · Cited by 196
Interaction of neuromelanin and iron in substantia nigra and other areas of human brain
Zecca, L., Shima, T., Stroppolo, A., Goj, C., Battiston, G. A., Gerbasi, R., Sarna, T., & Swartz, H. M. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00047-4 · Cited by 196
Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter
Whitehead, R. E., Ferrer, J. V., Javitch, J. A., & Justice, J. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00125.x · Cited by 194
Selective Vulnerability of Dopaminergic Neurons to Microtubule Depolymerization
Ren, Y., Liu, W., Jiang, H., Jiang, Q., & Feng, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503483200 · Cited by 188
Age-related Changes in Locus Ceruleus on Neuromelanin Magnetic Resonance Imaging at 3 Tesla
SHIBATA, E., SASAKI, M., TOHYAMA, K., KANBARA, Y., OTSUKA, K., EHARA, S., & SAKAI, A. (2006) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.5.197 · Cited by 185
Ultrastructural characterization of the acetylcholine innervation in adult rat neostriatum
Contant, C., Umbriaco, D., Garcia, S., Watkins, K. C., & Descarries, L. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00507-2 · Cited by 178
Stage‐dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease
Dijkstra, A. A., Voorn, P., Berendse, H. W., Groenewegen, H. J., Bank, N. B., Rozemuller, A. J. M., & van de Berg, W. D. J. (2014) · Movement Disorders · doi:10.1002/mds.25952 · Cited by 176
Rinne, J. O., Ma, S. Y., Lee, M. S., Collan, Y., & Röyttä, M. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.01.006 · Cited by 175
Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase
Xu, Y., Stokes, A. H., Roskoski, R., & Vrana, K. E. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981201)54:5<691::aid-jnr14>3.0.co;2-f · Cited by 175
Mundiñano, I.-C., Caballero, M.-C., Ordóñez, C., Hernandez, M., DiCaudo, C., Marcilla, I., Erro, M.-E., Tuñon, M.-T., & Luquin, M.-R. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0830-2 · Cited by 173
Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase
Sanchez-Padilla, J., Guzman, J. N., Ilijic, E., Kondapalli, J., Galtieri, D. J., Yang, B., Schieber, S., Oertel, W., Wokosin, D., Schumacker, P. T., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3717 · Cited by 172
Morphometry of the human substantia nigra in ageing and Parkinson’s disease
Rudow, G., O’Brien, R., Savonenko, A. V., Resnick, S. M., Zonderman, A. B., Pletnikova, O., Marsh, L., Dawson, T. M., Crain, B. J., West, M. J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0352-8 · Cited by 171
Duda, J., Pötschke, C., & Liss, B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13572 · Cited by 170
Pifl, C., Rajput, A., Reither, H., Blesa, J., Cavada, C., Obeso, J. A., Rajput, A. H., & Hornykiewicz, O. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5456-13.2014 · Cited by 167
Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease
Goldberg, J. A., Guzman, J. N., Estep, C. M., Ilijic, E., Kondapalli, J., Sanchez-Padilla, J., & Surmeier, D. J. (2012) · Nature Neuroscience · doi:10.1038/nn.3209 · Cited by 167
Dysautonomia in Parkinsonism: a clinicopathological study.
Rajput, A. H., & Rozdilsky, B. (1976) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.39.11.1092 · Cited by 164
The potential role of neuroinflammation and transcription factors in Parkinson disease
Tiwari, P. C., & Pal, R. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.1/rpal · Cited by 164
Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease
Milber, J. M., Noorigian, J. V., Morley, J. F., Petrovitch, H., White, L., Ross, G. W., & Duda, J. E. (2012) · Neurology · doi:10.1212/wnl.0b013e318278fe32 · Cited by 163
The locus ceruleus and dementia in Parkinson's disease
Zweig, R. M., Cardillo, J. E., Cohen, M., Giere, S., & Hedreen, J. C. (1993) · Neurology · doi:10.1212/wnl.43.5.986 · Cited by 161
Ma, S. Y., Röyttä, M., Rinne, J. O., Collan, Y., & Rinne, U. K. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00100-7 · Cited by 160
Laar, V. S. V., Mishizen-Eberz, A. J., Cascio, M., & Hastings, T. G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.03.004 · Cited by 154
Parkinson disease and incidental Lewy body disease: Just a question of time?
Iacono, D., Geraci-Erck, M., Rabin, M., Adler, C. H., Serrano, G. E., Beach, T. G., & Kurlan, R. (2015) · Neurology · doi:10.1212/wnl.0000000000002102 · Cited by 152
Orimo, S. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.776 · Cited by 150
Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy
Cabello, C. R., Thune, J. J., Pakkenberg, H., & Pakkenberg, B. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00393.x · Cited by 150
Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease
Benarroch, E. E., Schmeichel, A. M., Sandroni, P., Low, P. A., & Parisi, J. E. (2006) · Neurology · doi:10.1212/01.wnl.0000196638.98781.bb · Cited by 149
M itochondrial DNA and primary mitochondrial dysfunction in P arkinson's disease
Giannoccaro, M. P., Morgia, C. L., Rizzo, G., & Carelli, V. (2017) · Movement Disorders · doi:10.1002/mds.26966 · Cited by 144
Specific A10 Dopaminergic Nuclei in the Midbrain Degenerate in Parkinson's Disease
McRitchie, D. A., Cartwright, H., & Halliday, G. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6418 · Cited by 138
Zucca, F. A., Bellei, C., Giannelli, S. G., Terreni, M., Gallorini, M., Rizzio, E., Pezzoli, G., Albertini, A., & Zecca, L. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0453-2 · Cited by 138
Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress
Shi, H., Deng, H., Gius, D. R., Schumacker, P. T., Surmeier, D. J., & Ma, Y. C. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx100 · Cited by 138
Selective loss of pyramidal neurons in the pre‐supplementary motor cortex in Parkinson's disease
Macdonald, V., & Halliday, G. M. (2002) · Movement Disorders · doi:10.1002/mds.10258 · Cited by 136
Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing
Ma, Röytt, Collan, & Rinne (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00202.x · Cited by 136
MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease
Kosta, P., Argyropoulou, M. I., Markoula, S., & Konitsiotis, S. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0914-9 · Cited by 135
Cell death of dopamine neurons in aging and Parkinson’s disease
Naoi, M., & Maruyama, W. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(99)00064-0 · Cited by 134
Updates on immunity and inflammation in Parkinson disease pathology
Joshi, N., & Singh, S. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24185 · Cited by 134
Haacke, E. M., Miao, Y., Liu, M., Habib, C. A., Katkuri, Y., Liu, T., Yang, Z., Lang, Z., Hu, J., & Wu, J. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22293 · Cited by 133
ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway
Mercado, G., Castillo, V., Soto, P., & Sidhu, A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.042 · Cited by 133
Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts
Kraemmer, J., Kovacs, G. G., Perju-Dumbrava, L., Pirker, S., Traub-Weidinger, T., & Pirker, W. (2014) · Movement Disorders · doi:10.1002/mds.25975 · Cited by 132
Hoogendijk, W. J. G., Pool, C. W., Troost, D., van Zwieten, E. J., & Swaab, D. F. (1995) · Brain · doi:10.1093/brain/118.1.131 · Cited by 132
l-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease?
Lipski, J., Nisticò, R., Berretta, N., Guatteo, E., Bernardi, G., & Mercuri, N. B. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.06.005 · Cited by 131
Halliday, G. M., Macdonald, V., & Henderson, J. M. (2005) · Brain · doi:10.1093/brain/awh596 · Cited by 129
Histological changes of the dopaminergic nigrostriatal system in aging
Stark, A. K., & Pakkenberg, B. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0972-9 · Cited by 123
Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy
Schmeichel, A. M., Buchhalter, L. C., Low, P. A., Parisi, J. E., Boeve, B. F., Sandroni, P., & Benarroch, E. E. (2008) · Neurology · doi:10.1212/01.wnl.0000298691.71637.96 · Cited by 121
McMillan, P. J., White, S. S., Franklin, A., Greenup, J. L., Leverenz, J. B., Raskind, M. A., & Szot, P. (2010) · Brain Research · doi:10.1016/j.brainres.2010.12.015 · Cited by 119
Biochemical neuropathology of Parkinson's disease.
Javoy-Agid, F., Ruberg, M., Taquet, H., Bokobza, B., Agid, Y., Gaspar, P., Berger, B., Nguyen-Legros, J., Alvarez, C., & Gray, F. (1984) · PubMed · Cited by 119
Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease
Halliday, G. M., McRitchie, D. A., Cartwright, H., Pamphlett, R., Hely, M. A., & Morris, J. G. (1996) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(96)90083-1 · Cited by 115
Parkin-positive autosomal recessive juvenile parkinsonism with α-synuclein-positive inclusions
Sasaki, S., Shirata, A., Yamane, K., & Iwata, M. (2004) · Neurology · doi:10.1212/01.wnl.0000134657.25904.0b · Cited by 114
Age-related differences in iron content of subcortical nuclei observed in vivo: A meta-analysis
Daugherty, A. M., & Raz, N. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.12.040 · Cited by 110
Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease
Surmeier, D. J., Halliday, G. M., & Simuni, T. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.001 · Cited by 109
Gagnon, D., & Parent, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087709 · Cited by 107
Prigent, A., Agid, Y., & Hirsch, É. C. (1994) · Brain Research · doi:10.1016/0006-8993(94)90511-8 · Cited by 107
Dugger, B. N., Murray, M. E., Boeve, B. F., Parisi, J. E., Benarroch, E. E., Ferman, T. J., & Dickson, D. W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01203.x · Cited by 102
Locus ceruleus morphometry in aging and schizophrenia
Lohr, J. B., & Jeste, D. V. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb05189.x · Cited by 102
Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease
Xuereb, J. H., Perry, R. H., Candy, J. M., Perry, E. K., Marshall, E., & Bonham, J. R. (1991) · PubMed · doi:10.25405/ncl.34085541 · Cited by 99
THE PATHOLOGY OF CERTAIN MEDULLARY NUCLEI IN PARKINSONISM
Eadie, M. J. (1963) · Brain · doi:10.1093/brain/86.4.781 · Cited by 96
Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease.
Bertrand, E., Lechowicz, W., Szpak, G. M., & Dymecki, J. (1997) · PubMed · Cited by 95
Huisman, E., Uylings, H. B. M., & Hoogland, P. V. J. M. (2008) · Movement Disorders · doi:10.1002/mds.22009 · Cited by 95
Neuron loss in the nucleus basalis of meynert in parkinsonism‐dementia complex of Guam
Nakano, I., & Hirano, A. (1983) · Annals of Neurology · doi:10.1002/ana.410130118 · Cited by 91
GAI, W. P., Halliday, G. M., Blumbergs, P. C., Geffen, L. B., & Blessing, W. W. (1991) · Brain · doi:10.1093/brain/114.5.2253 · Cited by 89
Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease
Saper, C. B., Sorrentino, D. M., German, D. C., & Lacalle, S. D. (1991) · Annals of Neurology · doi:10.1002/ana.410290602 · Cited by 87
Age-related loss of dorsal vagal neurons in Parkinson's disease
Gai, W., Blumbergs, P. C., Geffen, L. B., & Blessing, W. W. (1992) · Neurology · doi:10.1212/wnl.42.11.2106 · Cited by 85
The basal nucleus of Meynert in idiopathic Parkinson's disease
Tagliavini, F., Pilleri, G., Bouras, C., & Constantinidis, J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb00798.x · Cited by 82
The number of nerve cells in the substantia nigra in paralysis agitans
Pakkenberg, H., & Brody, H. (1965) · Acta Neuropathologica · doi:10.1007/bf00686528 · Cited by 82
Gleave, J. A., Arathoon, L. R., Trinh, D., Lizal, K. E., Giguère, N., Barber, J., Najarali, Z., Khan, M. H., Thiele, S. L., Semmen, M. S., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.06.009 · Cited by 76
Self-citationPienaar, I. S., Elson, J. L., Racca, C., Nelson, G., Turnbull, D. M., & Morris, C. M. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.09.002 · Cited by 74
Purba, J. S., Hofman, M. A., & Swaab, D. F. (1994) · Neurology · doi:10.1212/wnl.44.1.84 · Cited by 73
Hippocampal neuron and glial cell numbers in Parkinson's disease—A stereological study
Joelving, F. C., Billeskov, R., Christensen, J. R., West, M. J., & Pakkenberg, B. (2006) · Hippocampus · doi:10.1002/hipo.20212 · Cited by 72
Cardiac denervation in patients with Parkinson disease.
Goldstein, D. S. (2007) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.74.suppl_1.s91 · Cited by 72
Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease
Wong, Y. C., & Krainc, D. (2016) · Movement Disorders · doi:10.1002/mds.26802 · Cited by 65
A Golgi study of human locus coeruleus in normal brains and in Parkinson's disease
Patt, S., & Gerhard, L. (1993) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1993.tb00480.x · Cited by 64
The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease
Kinghorn, K. J., Asghari, A., & Castillo-Quan, J. I. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.202934 · Cited by 61
Role of activity‐dependent mechanisms in the control of dopaminergic neuron survival
Michel, P. P., Alvarez‐Fischer, D., Guerreiro, S., Hild, A., Hartmann, A., & Hirsch, É. C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04424.x · Cited by 58
Meitzen, J., Pflepsen, K. R., Stern, C. M., Meisel, R. L., & Mermelstein, P. G. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.10.017 · Cited by 57
Nakamura, S., Ohnishi, K., Nishimura, M., Suenaga, T., Akiguchi, I., Kimura, J., & Kimura, T. (1996) · Neurology · doi:10.1212/wnl.46.6.1693 · Cited by 57
Hepp, D. H., Ruiter, A. M., Galis, Y., Voorn, P., Rozemüller, A. J. M., Berendse, H. W., Foncke, E. M. J., & van de Berg, W. D. J. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000014 · Cited by 55
No global loss of neocortical neurons in parkinson's disease: A quantitative stereological study
Pedersen, K. M., Marner, L., Pakkenberg, H., & Pakkenberg, B. (2004) · Movement Disorders · doi:10.1002/mds.20289 · Cited by 55
Differential degeneration of the locus coeruleus in dementia subtypes
Brunnström, H., Friberg, N., Lindberg, E., & Englund, E. M. (2011) · Clinical Neuropathology · doi:10.5414/npp30104 · Cited by 54
Gao, H., Glatzer, N. R., Williams, K. W., Derbenev, A. V., Liu, D., & Smith, B. N. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.024 · Cited by 53
Glucocerebrosidase deficits in sporadic Parkinson disease
Murphy, K. E., & Halliday, G. M. (2014) · Autophagy · doi:10.4161/auto.29074 · Cited by 53
DJ ‐1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7
Nottia, M. D., Masciullo, M., Verrigni, D., Petrillo, S., Modoni, A., Rizzo, V., Giuda, D. D., Rizza, T., Niceta, M., Torraco, A., et al. (2016) · Clinical Genetics · doi:10.1111/cge.12841 · Cited by 53
Y., S., Collan, Y. U., Röyttä, M., Rinne, J. O., & Rinne, U. K. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01023.x · Cited by 52
Serotonergic markers in Parkinson's disease and levodopa‐induced dyskinesias
Cheshire, P., Ayton, S., Bertram, K., Ling, H., Li, A., McLean, C., Halliday, G. M., O’Sullivan, S. S., Révész, T., Finkelstein, D. I., et al. (2015) · Movement Disorders · doi:10.1002/mds.26144 · Cited by 49
Rostral raphe involvement in Lewy body dementia and multiple system atrophy
Benarroch, E. E., Schmeichel, A. M., Sandroni, P., Parisi, J. E., & Low, P. A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0260-3 · Cited by 47
Ma, S. Y., Rinne, J. O., Collan, Y. U., Röyttä, M., & Rinne, U. K. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00069-x · Cited by 47
PINK1- and PARK2-mediated local mitophagy in distal neuronal axons.
Ashrafi, G., & Schwarz, T. L. (2015) · Europe PMC (PubMed Central) · doi:10.1080/15548627.2014.996021 · Cited by 46
Kremer, H. P. H. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)64576-8 · Cited by 44
Lewy bodies in the lateral hypothalamus: Do they imply neuronal loss?
Kremer, H. P. H., & Bots, G. T. A. M. (1993) · Movement Disorders · doi:10.1002/mds.870080310 · Cited by 43
Wr, G., Fearnley, J., & Aj, L. (1990) · PubMed · Cited by 43
Gao, K., & Mason, P. (1997) · The Journal of Comparative Neurology · Cited by 40
Gao, K., & Mason, P. (1997) · PubMed · Cited by 39
DJ-1 deficiency perturbs microtubule dynamics and impairs striatal neurite outgrowth
Sheng, C., Heng, X., Zhang, G., Xiong, R., Li, H., Zhang, S., & Chen, S. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.04.008 · Cited by 39
The Role of Axonopathy in Parkinson's Disease
O’Malley, K. L. (2010) · Experimental Neurobiology · doi:10.5607/en.2010.19.3.115 · Cited by 36
Age, environments, and the number of substantia nigra neurons.
Thiessen, B., Ah, R., Laverty, W., & Desai, H. (1990) · PubMed · Cited by 36
Neuronal loss and plasticity in the supraoptic nucleus in Parkinson's disease
Ansorge, O., Daniel, S. E., & Pearce, R. K. B. (1997) · Neurology · doi:10.1212/wnl.49.2.610 · Cited by 34
Age-related changes of neuronal counts in the human pedunculopontine nucleus
Ransmayr, G. N., Faucheux, B. A., Nowakowski, C., Kubis, N., Federspiel, S., Kaufmann, W. A., Hénin, D., Hauw, J. J., Agid, Y., & Hirsch, É. C. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01244-1 · Cited by 31
Cardiac sympathetic denervation preceding motor signs in Parkinson disease
Goldstein, D. S., Sharabi, Y., Karp, B. I., Bentho, O., Saleem, A., Pacák, K., & Eisenhofer, G. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76.s2.10 · Cited by 31
Wang, Z., Hou, L., Huang, L., Guo, J., & Zhou, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.010 · Cited by 29
Changes in dopaminergic neurons of the mesocorticolimbic system in Parkinson's disease.
Dymecki, J., Lechowicz, W., Bertrand, E., & Gm, S. (1996) · PubMed · Cited by 23
Hurley, M. J., Gentleman, S., & Dexter, D. T. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0410-8 · Cited by 19
Iron as a trigger of neurodegeneration in Parkinson's disease
Friedman, A., Gałązka-Friedman, J., & Bauminger, E. R. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83023-5 · Cited by 18
Nucleus raphe dorsalis in parkinsonism-dementia complex of Guam
Yamamoto, T., & Hirano, A. (1985) · Acta Neuropathologica · doi:10.1007/bf00687815 · Cited by 18
Cited by
Parkinson’s disease: etiopathogenesis and treatment
Jankovic, J., & Tan, E. K. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322338 · Cited by 1,169
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Ge, P., Dawson, V. L., & Dawson, T. M. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00367-7 · Cited by 496
Prodromal Parkinson disease subtypes — key to understanding heterogeneity
Berg, D., Borghammer, P., Fereshtehnejad, S.-M., Heinzel, S., Horsager, J., Schaeffer, E., & Postuma, R. B. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00486-9 · Cited by 409
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Henrich, M. T., Oertel, W. H., Surmeier, D. J., & Geibl, F. F. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00676-7 · Cited by 406
Metadata
- Authors
- Giguère, N., Burke Nanni, S., & Trudeau, L.-E.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2018-06-19
- Volume
- 9
- Pages
- 455-455
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W2806614570
- Cited by
- 413
- References
- 203
- FWCI
- 19.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.